107 related articles for article (PubMed ID: 1210314)
1. [Hormone therapy of breast cancer].
Zhivetskiĭ AV; Kleĭman SM; Petruk VI; Zhivetskiĭ VA
Vrach Delo; 1975 Sep; (9):99-101. PubMed ID: 1210314
[No Abstract] [Full Text] [Related]
2. [Hormone treatment of metastasizing breast carcinoma].
Navarra S; Melita P; Di Mauro S; Calbo L; Belnome N
Minerva Chir; 1981 Jun; 36(12):853-60. PubMed ID: 6454856
[TBL] [Abstract][Full Text] [Related]
3. [Hormonal therapy of the advanced breast cancer ].
Gürtler R; Matthes ML; Tanneberger S
Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
[TBL] [Abstract][Full Text] [Related]
4. [Endocrine therapy of breast cancer].
Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV
Sov Med; 1981; (12):54-9. PubMed ID: 7038903
[No Abstract] [Full Text] [Related]
5. [Steroid hormone receptors; their appearance in breast cancer; usefulness of the findings in the selection of patients for endocrine therapy and prognosis of tumor development].
Paszko Z; Padzik H; Pieńkowska F; Chrapusta S; Konopka B; Peczko D
Pol Tyg Lek; 1983 May 30-Jun 6; 38(22-23):677-83. PubMed ID: 6647135
[No Abstract] [Full Text] [Related]
6. [Complex treatment with radiation action on the hypophysis in generalized breast cancer].
Izmailova GE; Sviatukhina OV; Starichkov MS
Med Radiol (Mosk); 1974 Jul; 19(7):3-8. PubMed ID: 4409000
[No Abstract] [Full Text] [Related]
7. [Endocrine treatment of gynecologic neoplasms].
Maass H
Fortschr Med; 1980 Oct; 98(40):1551-3. PubMed ID: 7461551
[No Abstract] [Full Text] [Related]
8. Physicians changing postmenopausal sex hormone prescribing regimens.
Gruber JS; Luciani CT
Prog Clin Biol Res; 1986; 216():325-35. PubMed ID: 3725795
[No Abstract] [Full Text] [Related]
9. [Combined leukeran-prednisolone therapy in metastasizing breast cancer].
Cziráki L; Oó M
Fortschr Med; 1977 Apr; 95(15):1043-6. PubMed ID: 858580
[No Abstract] [Full Text] [Related]
10. Conservative treatment of benign prostatic hypertrophy.
Brosig W
Prog Clin Biol Res; 1976; 6():91-4. PubMed ID: 66699
[No Abstract] [Full Text] [Related]
11. [Hormone therapy and the risk of cancer in the climacteric].
Kuhl H; Taubert HD
Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599
[No Abstract] [Full Text] [Related]
12. Hormone replacement therapy and cancer.
Baber RJ; Studd JW
Br J Hosp Med; 1989 Feb; 41(2):142, 144-6, 148-9. PubMed ID: 2653531
[TBL] [Abstract][Full Text] [Related]
13. Combined medical and surgical therapy for endometriosis.
Wheeler JM; Malinak LR
Prog Clin Biol Res; 1990; 323():281-8. PubMed ID: 2137618
[No Abstract] [Full Text] [Related]
14. [Urgent problems of clinical practice in the conservative management of uterine myoma].
Vikhliaeva EM
Akush Ginekol (Mosk); 1980 Jan; (1):8-13. PubMed ID: 7377490
[No Abstract] [Full Text] [Related]
15. [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].
Jehn U; Sauer H; Wilmanns W
Klin Wochenschr; 1979 Sep; 57(18):913-20. PubMed ID: 388054
[TBL] [Abstract][Full Text] [Related]
16. [Chemical adrenalectomy--a new alternative in the treatment of advanced breast cancer].
Wilking N; Appelgren LE; Carlström K; Wallgren A; Theve T
Lakartidningen; 1983 Jun; 80(26-27):2644-5. PubMed ID: 6621193
[No Abstract] [Full Text] [Related]
17. [Dysfunctional uterine hemorrhages in the climacteric].
Prilepskaia VN
Akush Ginekol (Mosk); 1993; (6):9-14. PubMed ID: 8311165
[No Abstract] [Full Text] [Related]
18. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
19. Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study.
Rieche K; Wolff G
Arch Geschwulstforsch; 1975; 45(5):485-8. PubMed ID: 1243528
[TBL] [Abstract][Full Text] [Related]
20. [The molecular mechanisms of the action of steroid hormones and the reasons for breast cancer resistance to hormonal therapy].
Gnatyshak AI; Dryzhak VI
Vopr Onkol; 1991; 37(2):131-6. PubMed ID: 2014691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
